Pathways to prevention: the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) Program
Saved in:
| Main Authors: | Barnaby Nelson, Martha E. Shenton, Scott W. Woods, the Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ) |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-04-01
|
| Series: | Schizophrenia |
| Online Access: | https://doi.org/10.1038/s41537-025-00605-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Body fluid biomarkers and psychosis risk in The Accelerating Medicines Partnership® Schizophrenia Program: design considerations
by: Diana O. Perkins, et al.
Published: (2025-05-01) -
Data analysis strategies for the Accelerating Medicines Partnership® Schizophrenia Program
by: Nora Penzel, et al.
Published: (2025-04-01) -
Bridging Science and Hope: integrating and Communicating Lived experience in Accelerating Medicines Partnership® Schizophrenia Program
by: Ameneh Asgari-Targhi, et al.
Published: (2025-04-01) -
Digital health technologies in the accelerating medicines Partnership® Schizophrenia Program
by: Johanna T. W. Wigman, et al.
Published: (2025-06-01) -
The MR neuroimaging protocol for the Accelerating Medicines Partnership® Schizophrenia Program
by: Michael P. Harms, et al.
Published: (2025-04-01)